Literature DB >> 30833347

Mycobacterium tuberculosis Inhibits Autocrine Type I IFN Signaling to Increase Intracellular Survival.

Dallas A Banks1, Sarah E Ahlbrand1, V Keith Hughitt1,2, Swati Shah1, Katrin D Mayer-Barber3, Stefanie N Vogel4, Najib M El-Sayed1,2, Volker Briken5.   

Abstract

The type I IFNs (IFN-α and -β) are important for host defense against viral infections. In contrast, their role in defense against nonviral pathogens is more ambiguous. In this article, we report that IFN-β signaling in murine bone marrow-derived macrophages has a cell-intrinsic protective capacity against Mycobacterium tuberculosis via the increased production of NO. The antimycobacterial effects of type I IFNs were mediated by direct signaling through the IFN-α/β-receptor (IFNAR), as Ab-mediated blocking of IFNAR1 prevented the production of NO. Furthermore, M. tuberculosis is able to inhibit IFNAR-mediated cell signaling and the subsequent transcription of 309 IFN-β-stimulated genes in a dose-dependent way. The molecular mechanism of inhibition by M. tuberculosis involves reduced phosphorylation of the IFNAR-associated protein kinases JAK1 and TYK2, leading to reduced phosphorylation of the downstream targets STAT1 and STAT2. Transwell experiments demonstrated that the M. tuberculosis-mediated inhibition of type I IFN signaling was restricted to infected cells. Overall, our study supports the novel concept that M. tuberculosis evolved to inhibit autocrine type I IFN signaling to evade host defense mechanisms.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30833347      PMCID: PMC6456408          DOI: 10.4049/jimmunol.1801303

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

1.  Mycobacterium tuberculosis Differentially Activates cGAS- and Inflammasome-Dependent Intracellular Immune Responses through ESX-1.

Authors:  Ruth Wassermann; Muhammet F Gulen; Claudia Sala; Sonia Garcia Perin; Ye Lou; Jan Rybniker; Jonathan L Schmid-Burgk; Tobias Schmidt; Veit Hornung; Stewart T Cole; Andrea Ablasser
Journal:  Cell Host Microbe       Date:  2015-06-02       Impact factor: 21.023

2.  Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β.

Authors:  Bibhuti B Mishra; Vijay A K Rathinam; Gregory W Martens; Amanda J Martinot; Hardy Kornfeld; Katherine A Fitzgerald; Christopher M Sassetti
Journal:  Nat Immunol       Date:  2012-11-18       Impact factor: 25.606

3.  Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages.

Authors:  Aleksey Novikov; Marco Cardone; Robert Thompson; Kevin Shenderov; Kevin D Kirschman; Katrin D Mayer-Barber; Timothy G Myers; Ronald L Rabin; Giorgio Trinchieri; Alan Sher; Carl G Feng
Journal:  J Immunol       Date:  2011-07-22       Impact factor: 5.422

4.  Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents.

Authors:  Bo Zhou; Yantao He; Xian Zhang; Jie Xu; Yong Luo; Yuehong Wang; Scott G Franzblau; Zhenyun Yang; Rebecca J Chan; Yan Liu; Jianyu Zheng; Zhong-Yin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-18       Impact factor: 11.205

5.  The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation.

Authors:  Diane Ordway; Marcela Henao-Tamayo; Marisa Harton; Gopinath Palanisamy; Jolynn Troudt; Crystal Shanley; Randall J Basaraba; Ian M Orme
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

6.  Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates.

Authors:  I E Flesch; S H Kaufmann
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

7.  Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1.

Authors:  Chuan Xia; Madhuvanthi Vijayan; Curtis J Pritzl; Serge Y Fuchs; Adrian B McDermott; Bumsuk Hahm
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

Review 8.  Type I Interferons in Bacterial Infections: A Balancing Act.

Authors:  Pavel Kovarik; Virginia Castiglia; Masa Ivin; Florian Ebner
Journal:  Front Immunol       Date:  2016-12-26       Impact factor: 7.561

9.  Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis.

Authors:  Bibhuti B Mishra; Rustin R Lovewell; Andrew J Olive; Guoliang Zhang; Wenfei Wang; Eliseo Eugenin; Clare M Smith; Jia Yao Phuah; Jarukit E Long; Michelle L Dubuke; Samantha G Palace; Jon D Goguen; Richard E Baker; Subhalaxmi Nambi; Rabinarayan Mishra; Matthew G Booty; Christina E Baer; Scott A Shaffer; Veronique Dartois; Beth A McCormick; Xinchun Chen; Christopher M Sassetti
Journal:  Nat Microbiol       Date:  2017-05-15       Impact factor: 17.745

Review 10.  Type I interferons in tuberculosis: Foe and occasionally friend.

Authors:  Lúcia Moreira-Teixeira; Katrin Mayer-Barber; Alan Sher; Anne O'Garra
Journal:  J Exp Med       Date:  2018-04-17       Impact factor: 17.579

View more
  9 in total

Review 1.  Interferon-induced GTPases orchestrate host cell-autonomous defence against bacterial pathogens.

Authors:  Heike L Rafeld; Waldemar Kolanus; Ian R van Driel; Elizabeth L Hartland
Journal:  Biochem Soc Trans       Date:  2021-06-30       Impact factor: 5.407

Review 2.  Impact of Type I Interferons on Susceptibility to Bacterial Pathogens.

Authors:  Adeline Peignier; Dane Parker
Journal:  Trends Microbiol       Date:  2021-02-02       Impact factor: 18.230

Review 3.  Active Pulmonary Tuberculosis Triggered by Interferon Beta-1b Therapy of Multiple Sclerosis: Four Case Reports and a Literature Review.

Authors:  Carmen Adella Sirbu; Elena Dantes; Cristina Florentina Plesa; Any Docu Axelerad; Minerva Claudia Ghinescu
Journal:  Medicina (Kaunas)       Date:  2020-04-24       Impact factor: 2.430

4.  LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis.

Authors:  Chi G Weindel; Samantha L Bell; Krystal J Vail; Kelsi O West; Kristin L Patrick; Robert O Watson
Journal:  Elife       Date:  2020-02-14       Impact factor: 8.140

5.  Type I Interferons Are Involved in the Intracellular Growth Control of Mycobacterium abscessus by Mediating NOD2-Induced Production of Nitric Oxide in Macrophages.

Authors:  Jae-Hun Ahn; Ji-Yeon Park; Dong-Yeon Kim; Tae-Sung Lee; Do-Hyeon Jung; Yeong-Jun Kim; Yeon-Ji Lee; Yun-Ji Lee; In-Su Seo; Eun-Jung Song; Ah-Ra Jang; Soo-Jin Yang; Sung Jae Shin; Jong-Hwan Park
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

6.  Characterisation of secretome-based immune responses of human leukocytes infected with various Mycobacterium tuberculosis lineages.

Authors:  Benjawan Kaewseekhao; Sittiruk Roytrakul; Yodying Yingchutrakul; Marut Laohaviroj; Kanin Salao; Kiatichai Faksri
Journal:  PeerJ       Date:  2021-06-03       Impact factor: 2.984

7.  Type I interferon decreases macrophage energy metabolism during mycobacterial infection.

Authors:  Gregory S Olson; Tara A Murray; Ana N Jahn; Dat Mai; Alan H Diercks; Elizabeth S Gold; Alan Aderem
Journal:  Cell Rep       Date:  2021-06-01       Impact factor: 9.423

8.  Human Alveolar and Splenic Macrophage Populations Display a Distinct Transcriptomic Response to Infection With Mycobacterium tuberculosis.

Authors:  Lelia Lavalett; Hector Ortega; Luis F Barrera
Journal:  Front Immunol       Date:  2020-04-21       Impact factor: 7.561

Review 9.  Mycobacterial virulence: impact on immunogenicity and vaccine research.

Authors:  Vera M Kroesen; Jan Madacki; Wafa Frigui; Fadel Sayes; Roland Brosch
Journal:  F1000Res       Date:  2019-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.